Armistice Capital’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-560,000
Closed -$5.7M 251
2022
Q4
$5.7M Sell
560,000
-40,000
-7% -$407K 0.1% 93
2022
Q3
$3.53M Buy
600,000
+276,984
+86% +$1.63M 0.06% 106
2022
Q2
$801 Buy
+323,016
New +$801 0.01% 130